Coagulopathy (main): Difference between revisions
Neil.m.young (talk | contribs) m (Neil.m.young moved page Coagulopathy (Main) to Coagulopathy (main)) |
Neil.m.young (talk | contribs) No edit summary |
||
| Line 14: | Line 14: | ||
==See Also== | ==See Also== | ||
*[[Transfusions]] | *[[Transfusions]] | ||
*[[Idarucizumab]] | |||
==References== | ==References== | ||
[[Category:Heme/Onc]] | [[Category:Heme/Onc]] | ||
Revision as of 13:01, 14 December 2015
Differential Diagnosis
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Warfarin (Coumadin)
- Unfractionated heparin
- Low molecular weight heparin (i.e. enoxaparin (Lovenox), dalteparin)
- Factor Xa Inhibitors (e.g. rivaroxaban, apixaban, fondaparinux, edoxaban)
- Direct thrombin inhibitors (e.g. dabigatran, argatroban, bivalirudin)
- Illness induced
- Genetic
Increased Clotting
Managment
- Bleeding Treatments
- Procedures in patients with coagulopathies
- Reversing known medications